Guanabenz structure
|
Common Name | Guanabenz | ||
|---|---|---|---|---|
| CAS Number | 60329-03-5 | Molecular Weight | 231.08200 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C8H8Cl2N4 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Guanabenz(E)-Guanabenz ((E)-Wy-8678) is an orally active central α2-adrenoceptor agonist. (E)-Guanabenz has antihypertensive activity, acts via stimulating central α2-adrenoceptors, and reducing net sympathetic outflow into the periphery. (E)-Guanabenz also directly binds to and inhibits GADD34, and has neuroprotective activity. (E)-Guanabenz can be used for researching hypertension and Parkinson disease[1][2]. |
| Name | Guanabenz |
|---|
| Description | (E)-Guanabenz ((E)-Wy-8678) is an orally active central α2-adrenoceptor agonist. (E)-Guanabenz has antihypertensive activity, acts via stimulating central α2-adrenoceptors, and reducing net sympathetic outflow into the periphery. (E)-Guanabenz also directly binds to and inhibits GADD34, and has neuroprotective activity. (E)-Guanabenz can be used for researching hypertension and Parkinson disease[1][2]. |
|---|---|
| Related Catalog | |
| Target |
α2-adrenoceptor, GADD34[1][2] |
| References |
| Molecular Formula | C8H8Cl2N4 |
|---|---|
| Molecular Weight | 231.08200 |
| Exact Mass | 230.01300 |
| PSA | 76.76000 |
| LogP | 3.00130 |
| Precursor 0 | |
|---|---|
| DownStream 2 | |